Comparison of telomere length in patients with bone marrow failure syndromes and healthy controls

Abstract

AbstractIntroductionDuring normal aging, telomeric DNA is gradually lost in dividing somatic cells, and critically short telomeres lead to replicative senescence, apoptosis, or chromosomal instability. We studied telomere length in bone marrow failure syndromes (BMFS) compared to normal healthy population.MethodsPeripheral blood was collected from the participants, and genomic DNA was extracted. Relative telomere length was measured using a quantitative polymerase chain reaction. Statistical analysis was performed using SPSS and GraphPad Prism 8.2 software.ResultsThe median age of normal Indian population was 31 (0–60) years. As expected, telomere length (TL) showed a decline with age and no difference in TL between males and females. The median age of 650 patients with aplastic anemia (AA) was 30 (1–60) years. TL was significantly shorter in patients with AA compared to healthy controls (p < .001). In FA and MDS patients, TL was significantly shorter than age‐matched healthy controls (p = .028; p < .001), respectively. There was no difference between the median TL in age‐matched AA and FA patients (p = .727). However, patients with MDS had shorter TL than age‐matched AA (p = .031).ConclusionTL in BMF syndrome patients was significantly shorter than age‐matched healthy controls.